The future of patient-centered care.
Need more information?
Focusing on the person in personalized medicine-
An Advanced Network of Pharmaceutical Solutions
The global market for genetic testing is projected to reach $10.3 billion by 2024, driven by the aging population, rising incidence of genetically predisposed and hereditary diseases, growing awareness and technological advances. With the advent of advanced DNA analysis, the scope of genetic testing has expanded to embrace new application areas.
We work with CLIA certified labs to provide testing kits for:
There are no up-front costs for the patient or the clinic.
Copyright © TCS Pharmaceutical Enterprises. All rights reserved.